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Neurotrophins and their receptors play a fundamental role in the development and 
maintenance of neurons throughout the nervous system. They have a wide range of well 
documented functions within both the central nervous system (CNS) and peripheral nervous 
system (PNS) including established roles in neuronal differentiation, regulation of neurite 
outgrowth, synaptic regulation, cell survival and death. Many of the functions are context 
and tissue specific providing a highly versatile system for the development and maintenance 
of proper brain function(Dechant and Barde, 2002; Roux and Barker, 2002; Reichardt, 2006; 
Kraemer et al., 2014). The neurotrophin family is comprised of nerve growth factor (NGF), 
brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4 
(NT-4). Each neurotrophin exerts unique actions via interactions with specific high affinity 
tropomyosin regulated kinase (Trk) receptors. NGF interacts with TrkA, BDNF with TrkB, 
NT-3 with TrkC and to a lesser extent with TrkA and TrkB and NT-4 with TrkB. In addition 
to the Trk receptors, both the mature neurotrophins and their pro-neurotrophin precursors 
can bind to the p75 neurotrophin receptor (p75NTR) with low and high affinity, respectively. 
Signaling via the p75NTR is complex and many aspects are still poorly understood. The 
complexity is due, in part, to the many ways in which the receptor signals. At least four 
different processes may contribute to signaling specificity: 1) different heterodimeric 
neurotrophin receptor pairings, 2) activation by mature versus pro-neurotrophin, 3) post-
activation proteolytic processing and trafficking and 4) transactivation. Each process 
contributes in different ways to the development, maturation and maintenance of the nervous 
system. Excellent reviews are available that discuss, in greater detail, the diverse functions 
of the p75NTR (Dechant and Barde, 2002; Roux and Barker, 2002; Kraemer et al., 2014) and 
its association with other co-receptors (Underwood and Coulson, 2008; Skeldal et al., 2011; 
Ibanez and Simi, 2012; Kraemer et al., 2014).
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In addition to these functions, the p75NTR plays a less understood role in response to disease 
and injury. In this brief review we discuss the potential role of p75NTR expression in the 
adult nervous system and in response to nervous system injury and disease.
p75 NTR signaling partners
To understand the functions of the p75NTR, one must also understand the nature of its 
interactions with various co-receptors. The neurotrophin receptors can function as 
homodimers or heterodimers. The specific receptor interactions determine a wide range of 
signaling events and allow a few receptors to exert many different responses. The p75NTR, 
in particular, plays a pivotal role in neurotrophin receptor signaling through its interactions 
with three major signaling partners: Trk receptors (A, B and C), sortilin or Nogo receptors. 
A summary of p75NTR interactions with these receptors is illustrated in Figure 1.
Trk receptor-p75NTR interactions
The p75NTR is a single membrane spanning protein in the tumor necrosis factor (TNF) 
receptor family with four cysteine rich regions in the extracellular domain that are important 
for neurotrophin binding and receptor-receptor interactions. In contrast to the Trk receptors, 
the p75NTR does not have a catalytic domain for autophosphorylation, but instead contains a 
death domain similar in some ways to other TNF associated death domains. However, a 
major difference between the p75NTR and other death receptors is the inability of p75NTR to 
autoactivate. Because the p75NTR does not auto-phosphorylate or auto-activate, it exerts its 
functions by interacting with other receptors. Heterodimerization of p75NTR with Trk 
receptors increases the affinity of the mature neurotrophin/Trk interaction by about 100-fold 
and enhances pro-survival and growth signaling(Hempstead et al., 1991; Bibel et al., 1999). 
During development, the increased efficacy of p75NTR-TrkA signaling plays an important 
role in initiating NGF dependent growth and neuronal survival. Trk receptor signaling is 
typically mediated via downstream activation of pro-survival pathways such as PI3K-Akt, 
extracellular signal-regulated kinases (Erk) or phospholipase C-γ (PLCγ). In the absence of 
p75NTR signaling there is a reduced ability to activate Akt signaling via TrkA in PC12 cells 
(Bui et al., 2002; Ceni et al., 2010). In vivo, DRG neurons are highly dependent on the 
trophic effects of NGF and in mice lacking functional p75NTR there is decreased survival of 
these neurons(Hannila and Kawaja, 2003). The ability to interact with all Trk receptors 
affords the p75NTR with the opportunity to control many different aspects of neurotrophin 
signaling. This includes a growing appreciation for effects in the mature nervous system and 
responses to injury and disease. The functional consequences of these interactions are still 
being defined but should yield major insights into the processes that regulate neuronal 
growth, survival and plasticity under both normal and pathological conditions.
Sortilin-p75NTR interactions
The most widely studied non-Trk co-receptor with p75NTR is sortilin. Sortilin is a sorting 
protein with many functions(Nykjaer and Willnow, 2012). However, its interaction with 
p75NTR has received a great deal of attention due to two important discoveries; 1) p75NTR-
sortilin heterodimers activate apoptotic pathways in neurons and other cells, a process often 
used for cell selection during development (Hempstead, 2006; Kraemer et al., 2014) and 2) 
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pro-neurotrophins bind with high affinity to the sortilin-p75NTR complex and initiate cell 
death signaling(Lee et al., 2001) via the transcription factor JNK-3 and activation of c-Jun. 
The p75NTR has been shown to be important for initiation of apoptotic cell death in 
developing neurons(Huang and Reichardt, 2001; Teng et al., 2005; Jansen et al., 2007; 
Nykjaer and Willnow, 2012), retinal neurons(Frade and Barde, 1998; Roberti et al., 2014) 
sympathetic neurons(Kenchappa et al., 2010) and oligodendrocytes(Beattie et al., 2002). 
However, while sortilin’s role in cell death has received a great deal of attention, it is 
important to note that it is one of many functions. Sortilin functions principally as a sorting 
protein and most is found within late endosomes derived from the trans-Golgi network. In 
this context an important role of sortilin is to assist in anterograde trafficking of 
neurotrophin receptors and control of proBDNF secretion, important for neuronal function 
and survival(Vaegter et al., 2011). The potential role of sortilin in the trafficking of p75NTR 
is not known but could provide alternative signaling pathways that warrant further 
investigation.
Nogo receptor-p75NTR interactions
Interactions of p75NTR with the Nogo receptor provide additional mechanisms for control of 
growth. The myelin proteins Nogo, MAG or MOG bind to the Nogo receptor and suppress 
axonal growth via interactions with the p75NTR/Nogo receptor complex. The ligand-receptor 
complex activates the release of Rho-GDI from RhoA(Yamashita et al., 1999) via an 
interaction with LINGO-1(Mi et al., 2004) which triggers growth cone collapse. At the same 
time Rac is inhibited, further reducing the stimulus for growth cone formation(Deinhardt et 
al., 2011). These processes are important not only in development but also during recovery 
from injury and have been the focus of studies to develop therapies that restore neural 
growth(McDonald et al., 2011).
Interaction of p75NTR with truncated Trks
In addition to the classical Trk signaling, each Trk receptor has splice variants that lack the 
catalytic domain. The best characterized is truncated TrkB which is prominently expressed 
in the adult CNS and is thought to modify full length TrkB signaling. These splice variants 
work in concert with the p75NTR to control the formation of dendritic filopodia(Hartmann et 
al., 2004) and spines(Michaelsen et al., 2010). Transgenic mice overexpressing a truncated 
form of TrkB showed impaired maintenance of both long-term potentiation (LTP) and long-
term depression (LTD). Concomitant expression of p75NTR rescued these phenotypes 
suggesting that truncated TrkB may have a dominant negative relationship with the p75NTR 
(Michaelsen et al., 2010) which limits interactions with full length TrkB.
Receptor activation by mature versus pro-neurotrophin
Neurotrophins are synthesized as a pro-neurotrophin which is then proteolytically processed 
to the mature neurotrophin. Initially, the pro-neurotrophins were thought to be inactive 
precursors of the active mature peptides. With the later recognition that the pro-
neurotrophins are physiologically active came numerous studies showing that the pro-
neurotrophins were ligands for the p75NTR. It is now well recognized that neurotrophin 
signaling is dependent on the balance between mature vs. pro-neurotrophins as well as the 
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nature of the target receptor complex. The availability of high affinity targets for pro versus 
mature neurotrophins is highly regulated by the interactions of p75NTR with its receptor 
partner. In the case of Trk signaling, heterodimerization with p75NTR enhances mature 
neurotrophin signaling by increasing the binding affinity (Chao, 1994; Esposito et al., 2001; 
Hempstead, 2006) leading to increased cell survival, differentiation and growth. In contrast, 
interactions of p75NTR with sortilin promotes high affinity binding of pro-neurotrophins 
which activates pathways that lead to apoptotic cell death. The best studied of the pro-
neurotrophins is proNGF. ProNGF is synthesized and secreted by a variety of different cell 
types providing a rich source of cell-cell interactions(Hasan et al., 2003; Bruno and Cuello, 
2006; Domeniconi et al., 2007; Yang et al., 2009). Cleavage of proNGF can take place 
intracellularly by convertases or extracellularly by the enzymes, furin, plasmin and matrix 
metalloprotease-7 (MMP-7) (Lee et al., 2001; Teng et al., 2010). ProNGF and proBDNF 
have both been shown to trigger a p75NTR-dependent apoptotic cascade(Beattie et al., 2002; 
Harrington et al., 2004; Teng et al., 2005; Lebrun-Julien et al., 2010; Nykjaer and Willnow, 
2012). Confirmation of the role of each pro-neurotrophin was provided by demonstrating 
protection using specific antibodies to block the binding of proNGF(Harrington et al., 2004; 
Volosin et al., 2008) or proBDNF(Fan et al., 2008). The apoptotic cascade induced by 
proNGF and proBDNF was dependent on the interaction of p75NTR with the co-receptor 
sortilin since addition of a fusion molecule containing the extracellular domain of sortilin 
prevented the apoptotic effects of proBDNF. In p75NTR deficient mice, less cell death is 
seen after axotomy(Ferri et al., 1998; Syroid et al., 2000), seizures(Volosin et al., 2008) or 
ligation by proNGF(Beattie et al., 2002). Similar effects are seen after sortilin 
knockout(Jansen et al., 2007). Activation of the p75NTR/sortilin complex is thought to 
induce cell death through extended activation of c-Jun N-terminal protein kinase-3 (JNK-3) 
which in turn induces the synthesis of pro-apoptotic factors while also phosphorylating and 
inactivating anti-apoptotic factors(Kraemer et al., 2014). Induction of the apoptotic cascade 
may depend in part on proteolytic processing of the p75NTR (discussed below).
The dichotomy between the actions of mature neurotrophins versus pro-neurotrophins has 
led to the hypothesis that an imbalance may facilitate the progression of many 
neurodegenerative diseases including aging. The potential significance of proNGF signaling 
was further elevated by the observation that proNGF was the predominant form in human 
brain and was increased by two-fold in the parietal cortex of patients with Alzheimer disease 
(AD)(Fahnestock et al., 2001). A corresponding loss of TrkA in patients with AD(Counts et 
al., 2004; Ginsberg et al., 2006) and preservation of p75NTR and sortilin expression (Counts 
et al., 2004; Mufson et al., 2010) provided further support for a shift in pro versus mature 
neurotrophin signaling(Clewes et al., 2008; Mufson et al., 2008). Excess pro-neurotrophin 
signaling has also been implicated in the pathology associated with other neurodegenerative 
conditions. For example, the loss of MMP-7 activity in response to kainic acid induced 
seizures(Le and Friedman, 2012) and in diabetic retinopathy(Ali et al., 2011) is thought to 
contribute to the disease pathology by reducing the conversion of proNGF to NGF. 
However, other studies in HIV infected patients have shown that increases in MMP-7 
activity are associated with a decline in neurological function(Ragin et al., 2011). Further 
studies are needed to resolve the precise role of pro-neurotrophin processing in response to 
damage and disease. Nevertheless, these studies indicate that interventions designed to 
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restore a more favorable balance of mature neurotrophin-Trk protective signaling have the 
potential to slow neurodegenerative processes.
Post-activation proteolytic processing and trafficking of p75NTR
The contribution of p75NTR to neurotrophin signaling also depends on post-activation 
processing of the receptor. Following activation, p75NTR is proteolytically cleaved into 
fragments that possess specific signaling capacities. The proteolytic processing of the 
receptor termed regulated intra-membrane proteolysis (RIP) gives rise to receptor fragments 
compartmentalized within endosomes which can be transported to various sites for 
signaling, recycling or lysosomal destruction. As illustrated in Figure 1, initial cleavage of 
the p75NTR by TACE/ADAM17 gives rise to an extracellular N-terminal fragment and a C-
terminal fragment that is subsequently cleaved by the actions of γ-secretase to give the 
intracellular domain (ICD) that is responsible for signaling. Cytosolic trafficking of the 
endosome may divert the fragment to different proteins where it can have effects as diverse 
as survival signaling via interactions with a Trk receptor or apoptotic death via interactions 
with neurotrophin receptor interacting factor (NRIF)(Skeldal et al., 2011). Interactions with 
NRIF appear to cooperate with sortilin signaling by sustaining JNK activity. Other studies 
have suggested that the chopper domain of the ICD (Figure 1) may also function 
independently to induce cell death(Coulson et al., 2004). Although the p75NTR interacts with 
Trks in the membrane it may be processed separately since, with the exception of a small 
number of vesicles, it tends to be localized to distinctively different endosomes than 
Trks(McCaffrey et al., 2009). Endosomal trafficking of Trk receptors to the nucleus and 
subsequent transcriptional activation are known to mediate many of the long-term effects of 
neurotrophins. The significance of endosomal trafficking of the p75NTR ICD is less clear but 
associations with multiple processes including cell death, growth, differentiation and cell 
survival (Skeldal et al., 2011) suggest that sorting/trafficking mechanisms target the 
p75NTR-ICD containing endosomes to specific effector proteins.
Transactivation of Trk receptors
An additional, although less explored area of receptor interactions is the potential for 
transactivation within the membrane. Several receptors have been reported to catalyze the 
phosphorylation of the Trk receptors. This transactivation increases Akt activity and 
promotes survival signaling(Chao et al., 2006). The known transactivation events are 
accomplished through interactions with G-protein coupled receptors, such as the adenosine 
receptor. Because of the abundance of drugs within this class, efforts have been directed to 
the identification of pharmaceutical agents that may influence neurotrophin activity(Skaper, 
2008). Currently, no such relationships have been identified for the p75NTR. Nevertheless, 
since the p75NTR is a multifunctional protein that works in concert with other proteins, such 
interactions should not be ruled out.
P75NTR in the adult nervous system
In contrast to TrkA, B and C which are expressed in the adult nervous system and fulfill a 
variety of trophic functions, the expression of p75NTR is widely down regulated as the 
nervous system matures. Since only a few types of neurons retain relatively high levels of 
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expression into adulthood (e.g. sympathetic neurons, basal forebrain cholinergic neurons) 
the p75NTR has been viewed as having little role in the functions of the adult nervous 
system. However, this view is gradually being revised by studies that show low levels of 
endogenous expression and/or induced expression of p75NTR throughout the nervous 
system.
In an early study of the developmental expression of p75NTR in rat nervous system, 
expression of p75NTR mRNA in cerebellum, striatum, septum, medulla and pons persisted at 
low levels into adulthood(Ernfors et al., 1988). In the spinal cord, p75NTR expression 
decreased to undetectable levels from E8 to P1 but increased again in adults albeit at 
reduced levels relative to the high expression seen at E8. An in situ hybridization study of 
p75NTR mRNA expression in adult mouse brain showed expression in the hippocampus, 
cerebellum and septum at postnatal day 21(Zagrebelsky et al., 2005). P75NTR RNA was 
particularly high in the hippocampal dentate gyrus, CA1 and CA3 regions. Woo, et al. (Woo 
et al., 2005) also demonstrated expression of p75NTR protein in the juvenile (P14) and adult 
(P60) mouse hippocampus. Staining was seen in post-synaptic dendrites and spines 
indicating that the expression was synaptic and not restricted to presynaptic cholinergic 
fibers. These expression studies were supported by studies showing that p75NTR signaling 
played a role in the regulation of synaptic plasticity in the adult brain. An increase in 
dendrite complexity and spine density was seen in organotypic hippocampal explants from 
p75 exon IV null mice at P5 relative to age matched wild type mice, suggesting a normal 
role for the p75NTR in the negative modulation of dendrite and spine density(Zagrebelsky et 
al., 2005). Importantly, stimulation of hippocampal slices with proBDNF enhanced long-
term depression in a p75NTR-dependent fashion indicating that p75NTR plays a normal role 
in the regulation of synaptic plasticity, possibly via increased expression of NR2B(Woo et 
al., 2005) or shifts in the AMPA receptor GluR2/3 balance(Rosch et al., 2005). In vivo 
studies supported these observations by showing that p75NTR expression in adult 
hippocampal neurons was increased in aged rats with cognitive impairment(VanGuilder 
Starkey et al., 2013). Thus, qualitative shifts in plastic neural responses based on receptor 
availability may influence the efficiency of learning and memory processes. Synaptic spine 
modifications that restrict growth may underlie these changes in plasticity through p75NTR-
dependent mechanisms that activate RhoA and suppress Rac signaling(Yamashita and 
Tohyama, 2003; Gehler et al., 2004; Deinhardt et al., 2011; Sun et al., 2012).
The number of regions showing p75NTR expression and function in adult tissues is growing 
steadily and include motor axons, post-synaptic muscle and Schwann cells(Garcia et al., 
2010), retina(Hu et al., 1998), Muller glia(Lebrun-Julien et al., 2010), cochlea(Liu et al., 
2012), adult sensory neurons(Skoff and Adler, 2006) and neural progenitors(Young et al., 
2007). Expression of the p75NTR on adult neural progenitors may be particularly important 
for neurogenesis as only neurospheres generated from p75NTR-positive cells were 
neurogenic, possibly via a synergisitic effect on neuron production in response to BDNF or 
NGF stimulation(Young et al., 2007). The functional implications of these observations are 
still being explored but the findings clearly establish actions of p75NTR and pro-
neurotrophin signaling that contribute to neuronal plasticity in the adult nervous system.
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P75NTR expression in response to injury and disease
The above studies reflect a growing body of evidence suggesting that p75NTR may be 
expressed at low but functional levels in the adult nervous system. Alternatively, it is 
possible that p75NTR expression is induced as needed. In particular, many studies have 
demonstrated rapid upregulation of p75NTR in the nervous system under a variety of 
pathological conditions(Dechant and Barde, 2002; Chao et al., 2006; Ibanez and Simi, 2012; 
Kraemer et al., 2014). Such increases have been documented throughout the nervous 
system(Ibanez and Simi, 2012) and may be due to re-activation of developmental processes 
that support survival of the cell.
Injury
Increased expression of p75NTR in response to injury or stress has been seen in response to 
axotomy(Ernfors et al., 1989; Harrington et al., 2004), neural damage(Brunello et al., 1990; 
Beattie et al., 2002), intraocular pressure(Wei et al., 2007), seizures(Roux et al., 1999; 
Volosin et al., 2008) and ischemia(Kokaia et al., 1998). In addition to neurons, the increases 
in p75NTR may reflect expression in Schwann cells(Gai et al., 1996; Kobayashi et al., 2012; 
Richner et al., 2014), astrocytes(Cragnolini and Friedman, 2008; Cragnolini et al., 2009), 
oligodendrocytes(Dowling et al., 1999; Althaus and Richter-Landsberg, 2000; Casha et al., 
2001; Beattie et al., 2002; Petratos et al., 2004; Guo et al., 2013) and microglia/
macrophages(Dowling et al., 1999; Ozbas-Gerceker et al., 2004).
Much of the early work documenting changes in p75NTR expression was in studies of 
peripheral nerve damage. Nerve damage in the adult PNS induces mechanisms normally 
seen in development and has been termed a “regrowth mode” by Richner et al.( 2014). 
Repair is mediated in part by Schwann cells which show a robust up-regulation of p75NTR 
(Taniuchi et al., 1986). Migration of Schwann cells is inhibited by BDNF(Yamauchi et al., 
2004) and increased by NGF(Anton et al., 1994), both in a p75NTR-dependent fashion. Thus, 
the p75NTR may help to regulate the movement of Schwann cells to injured areas. Increases 
in p75NTR are also seen in peripheral neurons where there is a strong relationship between 
expression and the induction of apoptosis. This observation suggests that the induction of 
p75NTR is part of a process designed to promote apoptosis in damaged cells. However, 
although p75NTR function is associated with induction of apoptosis under many conditions, 
not all neurons co-expressing p75NTR with sortilin are affected by apoptosis-inducing injury 
(Arnett et al., 2007). This implies that there may be other roles of p75NTR yet to be explored.
In the CNS, increased expression of p75NTR has been demonstrated in spinal cord, 
brainstem, cerebellum, substantia nigra, cerebral cortex, hippocampus, basal forebrain and 
caudate-putamen(Ibanez and Simi, 2012). Expression is increased in substantia nigra 
dopamine neurons after kainic acid(Wang et al., 2008) and in the cortex and hippocampus 
after pilocarpine-induced seizures(Roux et al., 1999; Volosin et al., 2008). The p75NTR was 
dramatically upregulated in damaged cells within one day following cerebellar lesions 
(Martinez-Murillo et al., 1993) and within the striatum 20 min after cerebral ischemia 
(Kokaia et al., 1998), highlighting the capacity of adult neurons to rapidly induce the 
expression of the receptor. The expression after ischemia was transient and both functional 
and p75NTR recovery were seen at one week suggesting a close relationship between 
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p75NTR expression and the damage. Similarly, in retinal ischemia induced by elevated 
intraocular pressure, p75NTR was expressed in ganglion cells and the inner plexiform and 
nuclear layers(Wei et al., 2007). In contrast, no p75NTR expression was seen in normal 
retina. Overall, these studies indicate that p75NTR expression is a relatively common 
response to damage in both the PNS and CNS.
Neurodegenerative diseases
Increased expression of the p75NTR is also seen in a variety of neurodegenerative diseases. 
In aging and related neurodegeneration, studies have shown that p75NTR and sortilin 
expression in neurons increases while TrkA decreases(Harrington et al., 2004; Jansen et al., 
2007; Al-Shawi et al., 2008; Mufson et al., 2008; Terry et al., 2011) leading to the 
hypothesis that the p75NTR/TrkA ratio correlates with cell fate. In human AD, a detailed 
study of p75NTR expression in the membranes of hippocampal neurons showed a 2-fold 
increase(Chakravarthy et al., 2012) indicating that changes were not due to modifications to 
afferent cholinergic fibers. Increased expression of both p75NTR and TrkB has also been 
seen in the spinal cord of amyotrophic lateral sclerosis (ALS) patients(Seeburger et al., 
1993; Lowry et al., 2001) and ALS mouse models(Lowry et al., 2001). Using a temperature-
sensitive mutant of Moloney murine leukemia virus (MoMuLV-ts1) to induce experimental 
progressive spongiform encephalomyelopathy, Stoica, et al. (Stoica et al., 2008) observed 
intense immunoreactivity for proNGF, p75NTR and sortilin in regions with spongiform 
pathology. Expression of p75NTR under neurodegenerative conditions is not restricted to 
neurons as increases have been seen in all cell types within the nervous system. In multiple 
sclerosis plaques, oligodendrocytes and macrophage/microglia expressed increased levels of 
p75NTR (Dowling et al., 1999). Notably, only a fraction of these cells were apoptotic. The 
signals that drive the upregulation of p75NTR are not known but may include inflammatory 
influences. For example, a study of cellular p75NTR expression in vitro by Choi and 
Friedman (Choi and Friedman, 2009) demonstrated that expression could be induced by 
IL-1 or TNFα in hippocampal neurons and astrocytes. As with injury, an increase in p75NTR 
is a common response to neurodegenerative diseases reinforcing the view that it is a general 
response to a variety of stressors.
Effects of p75NTR upregulation
The above studies clearly illustrate that the capacity for rapid expression of p75NTR is 
widespread throughout the adult nervous system but why do these cells increase expression 
of p75NTR in response to damage? Is it to promote apoptotic death of cells and limit 
inflammation or to support survival and functional recovery of damaged cells? Evidence 
exists in support of both possibilities. In the majority of studies showing p75NTR 
upregulation, the increases correlated with the presence of apoptotic cells(Kraemer et al., 
2014) and p75NTR knockdown is widely protective in a variety of models(Underwood and 
Coulson, 2008). For example, ALS disease progression is delayed by p75NTR 
knockdown(Turner et al., 2003). In the mutant SOD1 mouse, an ALS model which develops 
severe neurodegeneration, an increase in the expression of p75NTR (little to no expression 
detected in control mice) and RIP fragments correlated with the extent of 
degeneration(Perlson et al., 2009). In animal models of AD, experimental studies showed 
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that p75NTR contributed to amyloidβ (Aβ )-induced neural damage(Perini et al., 2002; 
Knowles et al., 2009; Sotthibundhu et al., 2009). The contribution of the p75NTR may be 
mediated in part by the binding of Aβ to the receptor(Yaar et al., 1997; Perini et al., 2002).
Interactions of Aβ with the p75NTR has become a focus of recent studies of AD pathogenesis 
and may reveal yet another functional role for the p75NTR. Increases in proNGF in AD and 
Parkinson disease(Fahnestock et al., 2001; Peng et al., 2004; Pedraza et al., 2005; Chen et 
al., 2008) indicate that the environment is favorable for p75NTR signaling and supports the 
theory that age-related damage is due to a shift toward proNGF/p75NTR signaling versus 
beneficial NGF/TrkA signaling.
While the above studies paint an ominous picture of p75NTR upregulation in the nervous 
system, the role of p75NTR may be far from deadly. Many other studies also support the idea 
that p75NTR plays an essential role in protection and recovery of the nervous system. For 
example, proliferating satellite glia in the injured DRG express p75NTR and are found where 
sympathetic sprouting is seen(Zhou et al., 1996). The sprouting is attenuated in p75NTR null 
mice indicating an essential role for p75NTR in re-growth(Ramer and Bisby, 1997). In 
studies of motor neuron injury, the introduction of grafted Schwann cells deficient in 
p75NTR resulted in less motor neuron survival(Tomita et al., 2007). Also, BDNF is a 
positive modulator of myelination via p75NTR (Cosgaya et al., 2002; Song et al., 2006; 
Tomita et al., 2007) during peripheral nerve recovery, and p75NTR knockout impairs re-
myelination of injured sciatic nerve(Song et al., 2006). Thus p75NTR appears to play a 
pivotal role in Schwann cell support of neuron survival and regrowth. These positive effects 
of p75NTR may be mediated via pro-growth interactions with TrkB. Beneficial effects of 
p75NTR may also extend to its interactions with sortilin since the lack of sortilin function in 
knockout mice synergizes with a loss of p75NTR to produce a severe late-onset sensory 
neuropathy (Vaegter et al., 2011). Positive effects of p75NTR are also seen in the adult CNS 
where several studies have demonstrated that p75NTR has protective effects in 
AD(Bengoechea et al., 2009; Sotthibundhu et al., 2009; Wang et al., 2011).
The above observations highlight the complex and diverse roles of the p75NTR that range 
from apoptotic death to neuroprotection and plasticity. Rapid expression in response to 
various challenges indicate that the receptor is dynamically regulated. Some theories have 
suggested that the increase in p75NTR in response to injury or disease is a major factor 
contributing to neurodegeneration and there is strong evidence to support this view. On the 
other hand, studies also clearly demonstrate the beneficial role of the p75NTR. Thus, the 
p75NTR should be viewed as a flexible modulator of neurotrophin actions with the functional 
impact depending on specific interactions with co-receptors, availability of ligands, 
proteolytic processing and selection of signaling pathways. We have only begun to 
understand these actions and considerable work is needed to appreciate how p75NTR 
regulates nervous system functions in both normal and disease states.
P75NTR in the immune system
Our understanding of the role of p75NTR in the damaged nervous system would not be 
complete without mention of an additional target for neurotrophin interactions that may play 
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an important role in pathogenesis: p75NTR expression on immune cells. As early as 1996 
Levi-Montalcini (Levi-Montalcini et al., 1996) introduced the idea that neurotrophins may 
regulate the immune response. Since this early observation, a handful of studies have 
explored neurotrophin receptor gene transcript expression and immunoreactivity in immune 
cells in blood and various tissues. These studies have shown that the p75NTR is 
constitutively expressed on many types of immune cells and can be upregulated in response 
to injury. This provides considerable opportunity for neurotrophin regulation of immune cell 
function, particularly in the nervous system where neurotrophins are abundant. However, 
this aspect of neuroimmune interactions has received little attention. Table 1 summarizes 
studies that have documented expression of p75NTR in various immune cells.
Lymphocytes
Although TrkA receptors have been reported on CD3+ T lymphocytes, p75NTR expression 
was absent or negligible in T lymphocytes from blood, tonsil, and inflamed muscle, (Sariola, 
2001; Rogers et al., 2010; Raychaudhuri et al., 2011; Colombo et al., 2012). Expression of 
p75NTR, however, has been found at moderate levels in CD20+ B cells under some 
circumstances. Although expression of the p75NTR was negligible on the surface of B cells 
in blood from healthy patients(Rogers et al., 2010) it was identified at very low levels in 
inflamed muscle tissue (Colombo et al., 2012) and relatively high levels in thymus explants 
from myasthenia gravis patients(Berzi et al., 2008). Flow cytometry of cells isolated from 
involuted and hyperplastic thymus tissue found that 25% of B lymphocytes expressed 
p75NTR, whereas only 3% of the B cells were p75NTR-positive in neoplastic thymoma tissue 
samples illustrating selectivity in the induction of the receptor. In hyperplastic thymus 
samples, p75NTR overlapped with proliferating marker, ki-67, implicating its involvement in 
B cell proliferation (Berzi et al., 2008). Natural killer (NK) cells isolated from human blood 
also expressed low levels of p75NTR intracellularly but not extracellularly. Stimulation of 
the NK cells with IL-2 or IL-12 increased p75NTR expression by up to 10-fold (Rogers et al., 
2010). Induction of p75NTR expression by IL-2 was also seen in NK cells isolated from 
mouse spleen with low levels of endogenous p75NTR expression(Ralainirina et al., 2010) 
indicating that the receptors are robustly mobilized in response to inflammatory cytokines.
Granulocytes
Expression of the p75NTR has been documented in human skin mast cells(Fischer et al., 
2008) and eosinophils isolated from blood of atopic dermatitis patients(Raap et al., 2005). 
P75NTR expression in eosinophils was increased about 2-fold and lesional mast cells about 
5-fold in the atopic dermatitis patients compared to control patients(Raap et al., 2005). 
Basophils isolated from healthy donor blood were reported to have negligible p75NTR 
expression by flow cytometry yet were positive for p75NTR mRNA(Burgi et al., 1996). The 
increases in p75NTR expression seen in the eosinophils and mast cells again illustrate that 
the upregulation is a response shared by different cell types during injury.
Macrophages/microglia
P75NTR expression has been identified in cells of the monocytic lineage in various tissues. 
Low to moderate p75NTR expression was seen in macrophages in inflamed muscle 
tissue(Colombo et al., 2012) and in human monocyte derived macrophages (hMDM) from 
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blood(Caroleo et al., 2001; Aronica et al., 2004). In contrast, p75NTR expression was absent 
in macrophages in the thymus and tonsils(Labouyrie et al., 1997) suggesting that expression 
may be tissue or context specific. Microglia cells, the resident macrophages of the brain, 
showed weak p75NTR expression in white matter regions of normal brain but expression was 
increased in glial cell bodies and large patches of macrophages/microglia in white matter 
MS plaques, as well as in glioblastoma, ALS or HIV encephalopathy (Dowling et al., 1999). 
Garaci et al. found 15% of HIV-infected macrophages were immunoreactive for p75NTR in 
culture. P75NTR expression was increased to 35% with NGF starvation and was 
accompanied by an initiation of apoptosis in approximately 45% of HIV- infected cultured 
macrophages (Garaci et al., 1999). In a similar fashion, p75NTR expression was moderate to 
strong in microglial-like cells positive for tal1b5 and CD68 surrounding blood vessels and 
neurons in frontal cortical dysplasia, glioneuronal tumors and dysplastic neuronal 
tissue(Aronica et al., 2004). There were no Trk receptors found in these samples suggesting 
a primary role for p75NTR in these disease states. Moderate to strong p75NTR expression was 
also found in microglia in hippocampal sclerosis samples from temporal lobe epilepsy 
patients (Ozbas-Gerceker et al 2004). Immune interactions between neurons and microglia 
may also be regulated by the p75NTR. When neural activity in rat hippocampus was blocked 
with tetrodotoxin (TTX), the induction of major histocompatibility complex (MHC) class II 
in microglia by interferon-γ was increased. This immune activation of microglia was 
blocked by NGF via a mechanism dependent on microglial p75NTR signaling(Neumann et 
al., 1998). In some studies, the p75NTR was co-expressed in microglia positive for Trk 
receptors, indicating potential receptor interactions in these cells (Nakajima et al 1998). On 
close examination of the expression of p75NTR and TrkA on hMDM in vitro, we have seen 
that the two receptors are enriched in small domains on membrane ruffles (Fig 2). The 
intensity of stain can vary greatly with morphological phenotype suggesting a link between 
p75NTR expression and structural modifications. The functional significance of these 
receptors is only now beginning to be explored.
In addition to the expression of neurotrophin receptors, activated microglia/macrophages can 
release neurotrophins(Heese et al., 1998; Srinivasan et al., 2004; Ulmann et al., 2008) 
providing the capacity for autocrine feedback. Thus, the expression of p75NTR on immune 
cells and macrophages/microglia, in particular, raises the possibility of a host of neuro-
immune interactions that have not yet been investigated.
Therapeutic approaches targeted to p75NTR
The potential protective effects of neurotrophins have been the focus of a long history of 
efforts to develop therapies that take advantage of their beneficial effects(Aloe et al., 2012; 
Longo and Massa, 2013; Steiner and Nath, 2014). These efforts include clinical trials with 
neurotrophins directly delivered to neural tissue and the implantation of vectors and cells 
engineered to release neurotrophins. More recently, efforts have been directed to the 
potential use of non-peptide drugs that directly influence neurotrophin receptor 
function(Longo and Massa, 2013) or have indirect effects on neurotrophin signaling via 
transactivation or induction of neurotrophin secretion(Tanis et al., 2007; Obianyo and Ye, 
2013; Steiner and Nath, 2014). The potential role of the p75NTR as a therapeutic target for 
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the treatment of neurodegenerative diseases has been recognized in recent reviews(Chen et 
al., 2008; Ibanez and Simi, 2012; Longo and Massa, 2013).
The upregulation of p75NTR in neurons and other cells in response to injury or stress makes 
it possible to selectively target changes directly associated with the disease processes with 
minimal impact on normal tissues. This selectivity makes the p75NTR an attractive candidate 
for therapy and has encouraged the development of research strategies to better understand 
the role of p75NTR in response to damage. Additional features that make the p75NTR an 
excellent candidate for therapeutic modulation include its ability to exert a wide range of 
actions. Small non-peptide ligands in particular may be attractive since they have the 
potential to interact selectively with the many different binding/interacting domains on 
neurotrophin receptor monomers or dimers(Longo and Massa, 2013). Because the small 
molecule ligands are incapable of recapitulating the multi-domain binding of the naturally 
occurring proteins, they do not function as “agonists” or “antagonists” but most likely exert 
selective modulatory influences capable of “steering” a response in particular directions. For 
example, the experimental TrkA ligand, MT2, influences the TrkA tyrosine phosphorylation 
pattern resulting in NGF-like pro-survival activity with significantly less effect on 
differentiation(Scarpi et al., 2012). Such modulatory effects may minimize adverse effects 
resulting from excessive neurotrophin stimulation or blockade via potent agonists or 
antagonists. Promising results have recently been published that demonstrate the therapeutic 
utility of compounds that target the p75NTR. Nanomolar concentrations of the experimental 
compound, LM11A-31, a non-peptide structural mimetic of loop1 of NGF, have been shown 
to have neurotropic properties and to offer potent neuroprotection from Aβ induced damage 
in mouse and culture models of AD(Yang et al., 2008; Knowles et al., 2009; Nguyen et al., 
2014), spinal cord injury(Tep et al., 2013), traumatic brain injury(Shi et al., 2013), virus-
induced inflammation(Meeker et al., 2011), chemotherapeutic toxicity(James et al., 2008) as 
well as protection against apoptotic effects normally induced in oligodendrocytes by p75NTR 
ligation(Massa et al., 2006). A structurally unrelated compound similarly modeled after loop 
1of NGF and targeted to the p75NTR, LM11A-24, also protected against motor neuron 
degeneration(Pehar et al., 2006). Although these efforts are still in early stages of 
development they provide strong proof of concept that p75NTR is an important target for the 
development of therapies designed to influence neurotrophin signaling.
Conclusions
The p75NTR is a multifunctional receptor that can heterodimerize with TrkA, TrkB, TrkC, 
sortilin or the Nogo receptor to regulate a wide array of functions. In addition to the variety 
of receptor partners, signaling is modified by proteolytic processing of the receptor, 
trafficking to different targets and differential interactions with mature versus pro-
neurotrophins. The functional consequences of activation of p75NTR complexes and the 
various signaling pathways can range from growth and survival to cell death depending on 
the molecular and cellular context. Increasing evidence for expression and function in the 
mature nervous system is exemplified by the demonstrated role of the p75NTR in synaptic 
plasticity. Widespread upregulation in response to injury or disease underscores a prominent 
although poorly understood role for the p75NTR. Evidence exists for both pro-apoptotic and 
protective effects of the p75NTR in the damaged nervous system emphasizing the need to 
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fully understand the context of p75NTR expression. In addition, expression of the p75NTR on 
immune cells, particularly macrophages and microglia, indicate that the effects of the 
p75NTR may extend beyond neurons and glia and will likely encompass a range of 
neuroimmune interactions. Recent studies of small non-peptide p75NTR ligands have 
demonstrated potent neuroprotective effects in models of injury and neurodegenerative 
diseases that highlight the importance of the p75NTR as a therapeutic target. The functions of 
the p75NTR in the adult nervous system are still poorly understood and future studies in this 
area hold the promise of revealing a wealth of information on the multifaceted actions of 
neurotrophins in the context of normal and disease states.
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Neurotrophins and their respective tropomyosin related kinase (Trk) receptors (TrkA, 
TrkB, and TrkC) and the p75 neurotrophin receptor (p75NTR) play a fundamental role in 
the development and maintenance of the nervous system making them important targets 
for treatment of neurodegenerative diseases. Whereas Trk receptors are directly activated 
by specific neurotrophins, the p75NTR is a multifunctional receptor that exerts its effects 
via heterodimeric interactions with TrkA, TrkB, TrkC, sortilin or the Nogo receptor to 
regulate a wide array of cellular functions. By partnering with different receptors the 
p75NTR regulates binding of mature versus pro-neurotrophins and access to numerous 
signaling pathways with outcomes ranging from growth and survival to cell death. While 
the developmental downregulation of the p75NTR has raised questions regarding its role 
in the mature nervous system, recent data have revealed widespread expression of low 
levels, a role in synaptic plasticity and adult neurogenesis and upregulation in response to 
injury or disease. Studies are needed to better understand these processes, particularly in 
the damaged nervous system, but will be complicated by expression of p75NTR on 
immune cells including macrophages and microglia that are intimately involved in 
disease and repair processes. Recent approaches that regulate p75NTR function with small 
non-peptide ligands have demonstrated potent neuroprotection in models of injury and 
neurodegenerative diseases that highlight the importance of the p75NTR as a therapeutic 
target. Future studies hold the promise of revealing a wealth of information on the 
multifaceted actions of the p75NTR that will inform the design of new neurotrophin-based 
therapies.
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Signaling partners of the p75NTR. The p75NTR is a single membrane-spanning receptor in 
the tumor necrosis factor (TNF) receptor family with four cysteine-rich extracellular 
domains that bind each of the four neurotrophins: NGF, BDNF, NT-3 or NT-4 with low 
affinity and their respective pro-forms with high affinity. The intracellular portion of the 
receptor contains a death domain that does not self activate thereby requiring interactions 
with other effector proteins. The intracellular domain also includes a chopper domain that 
may independently interact with APAF-1 to induce apoptosis. The p75NTR can interact with 
at least three different receptor classes which mediate different outcomes: Trk receptors, 
sortilin and Nogo receptor. 1) Heterodimerization with Trk receptors increases the affinity of 
the mature neurotrophin/Trk interaction and enhances pro-survival and growth signaling via 
PI3K-Akt, ERK or PLCγ pathways and downstream effectors such as TRAF6 and NFκB. 
Activated Trk receptors phosphorylate TACE/ADAM17 which initiates p75NTR cleavage. 
The receptor is further cleaved by γ-secretase which generates the intracellular domain 
(ICD) within endosomes. The ICD subserves a variety of functions depending on the fate of 
the endosome. Selective endosomal trafficking to sites of interaction with other proteins may 
determine to a large degree the outcome of p75NTR activation. Interactions of the ICD with 
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neurotrophin receptor interacting factor (NRIF) may support apoptosis whereas interactions 
with Trk receptors may promote survival. 2) Interactions of p75NTR with sortilin allow high 
affinity binding of the pro-neurotrophins to the p75NTR/sortilin complex. Subsequent 
activation of the Ras/MAPK pathway and activation of JNK3 lead to apoptosis. However, 
most sortilin is found within late endosomes derived from the trans-Golgi network and may 
function independently to support neuron survival via anterograde trafficking of 
neurotrophin receptors and control of proBDNF secretion. 3) Interactions of the p75NTR 
with the Nogo receptor and Lingo-1 play a role in the control of growth. Activation of RhoA 
by displacement of Rho-GDI and a concurrent suppression of Rac leads to collapse of 
growth cones, neurite retraction and decreases in spine density. An additional source of 
signaling is suggested by the transactivation (phosphorylation) of Trk receptors by G-protein 
coupled receptors. Although there are currently no known G-protein interactions with the 
p75NTR efforts are underway to identify potential trans-acting ligands that modify 
neurotrophin signaling. These various interactions affords the p75NTR the capacity to play a 
pivotal role in the regulation of numerous processes that determine the fate and functions of 
the cell.
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P75NTR and TrkA expression on cultured human monocyte-derived macrophages. Example 
of a highly ruffled macrophage (middle) in culture flanked by more ameboid macrophages 
(upper left and right). The expression of both p75NTR (green) and TrkA (red) is highly 
enriched on ruffled membranes and finger-like folds. Discrete foci where the two receptors 
overlap are occasionally seen (yellow regions) but receptors were more typically localized to 
adjacent, non-overlapping domains. Inset: Highly magnified view of the ruffled membrane 
showing the focal expression of TrkA relative to the more widely distributed p75NTR stain.
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Table 1
Expression of p75NTR in cells of the immune system.
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Ralainirina et al. 2010
Rogers et al. 2010
Basophils Blood Negligible(detectable mRNA) Burgi et al. 1996
Eosinophils Blood 10% Atopicdermatitis Raap et al. 2005














Colombo et al. 2012
Labouyrie et al. 1997
Caroleo et al. 2001











Dowling et al. 1999
Neumann et al. 1998
Aronica et al. 2004
Ozbas-Gerceker et al. 2004
Macrophages/
Microglia in vitro Moderate to strong
Garaci et al. 1999
Nakakima et al. 1998
Heese et al. 1998
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